We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Warning Letter Hits India’s Ipca Labs on Allegations of Data Manipulation
Warning Letter Hits India’s Ipca Labs on Allegations of Data Manipulation
The FDA has slammed yet another Indian drugmaker for data integrity issues. This time it rebuked Ipca Laboratories for data falsification at three of the company’s manufacturing facilities.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor